MedPath

扬子江药业集团南京海陵药业有限公司

Ownership
-
Established
2001-01-16
Employees
-
Market Cap
-
Website
http://www.hailingyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

46

NMPA:46

Drug Approvals

Edoxaban Tosilate Tablets

Product Name
甲苯磺酸艾多沙班片
Approval Number
国药准字H20253550
Approval Date
Mar 4, 2025
NMPA

Edoxaban Tosilate Tablets

Product Name
甲苯磺酸艾多沙班片
Approval Number
国药准字H20253549
Approval Date
Mar 4, 2025
NMPA

Voriconazole Tablets

Product Name
伏立康唑片
Approval Number
国药准字H20237144
Approval Date
Nov 2, 2023
NMPA

Voriconazole for Injection

Product Name
注射用伏立康唑
Approval Number
国药准字H20233128
Approval Date
Feb 7, 2023
NMPA

Pregabalin Capsules

Product Name
普瑞巴林胶囊
Approval Number
国药准字H20223587
Approval Date
Aug 10, 2022
NMPA

Pregabalin Capsules

Product Name
普瑞巴林胶囊
Approval Number
国药准字H20223588
Approval Date
Aug 10, 2022
NMPA

Levetiracetam Tablets

Product Name
左乙拉西坦片
Approval Number
国药准字H20223194
Approval Date
Mar 29, 2022
NMPA

Levetiracetam Tablets

Product Name
左乙拉西坦片
Approval Number
国药准字H20223193
Approval Date
Mar 29, 2022
NMPA

Aripiprazole Orally Disintegrating Tablets

Product Name
阿立哌唑口崩片
Approval Number
国药准字H20223156
Approval Date
Mar 22, 2022
NMPA

Aripiprazole Orally Disintegrating Tablets

Product Name
阿立哌唑口崩片
Approval Number
国药准字H20223155
Approval Date
Mar 22, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.